Katherine Stemke‐Hale

23.0k citations

54 papers · 11.4k indexed · 2 hit papers · h-index 30

Molecular Biology top 0.5%
Oncology top 0.2%
Pulmonary and Respiratory Medicine top 0.2%
Cancer Research top 0.2%
Immunology top 1%

Co-authors: Gordon B. Mills Wandaliz Torres‐García Emmanuel Martínez Douglas A. Levine Hui Shen Roel G.W. Verhaak Víctor Treviño Kosuke Yoshihara
Topics: PI3K/AKT/mTOR signaling in cancer (9 papers)Cancer Genomics and Diagnostics (8 papers)Melanoma and MAPK Pathways (7 papers)
Cited by: Cancer Research Oncology Pulmonary and Respiratory Medicine
Journals: Journal of Biological Chemistry Nature Medicine Nature Communications
Partner nations: United States United Kingdom Ireland

In The Last Decade

Katherine Stemke‐Hale

52 papers receiving 11.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inferring tumour purity and stromal and immune cell admixture from expression data

2013 6.1k citations Katherine Stemke‐Hale, Gordon B. Mills et al. profile →
A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer

2007 1.2k citations Bryan T. Hennessy, Ana M. González-Angulo et al. profile →

Peers

Countries citing papers authored by Katherine Stemke‐Hale

Since Specialization

Citations

This map shows the geographic impact of Katherine Stemke‐Hale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Stemke‐Hale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Stemke‐Hale more than expected).

Fields of papers citing papers by Katherine Stemke‐Hale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Stemke‐Hale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Stemke‐Hale. The network helps show where Katherine Stemke‐Hale may publish in the future.

Co-authorship network of co-authors of Katherine Stemke‐Hale

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Stemke‐Hale. A scholar is included among the top collaborators of Katherine Stemke‐Hale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Stemke‐Hale. Katherine Stemke‐Hale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hypoxia-Driven TGFβ Modulation of Side Population Cells in Breast Cancer: The Potential Role of ERα 2023 ·Cancers ·(unknown),(unknown),(unknown),Thomas W. J. Lennard,(unknown),Dan Wei,Katherine Stemke‐Hale,John A. Kirby,Gendie E. Lash,Annette Meeson	4
2	A Comprehensive Evaluation of Biomarkers Predictive of Response to PI3K Inhibitors and of Resistance Mechanisms in Head and Neck Squamous Cell Carcinoma 2014 ·Molecular Cancer Therapeutics ·Tuhina Mazumdar,Lauren A. Byers,Patrick Kwok Shing Ng,Gordon B. Mills,Shaohua Peng,Lixia Diao,You-Hong Fan,Katherine Stemke‐Hale,John V. Heymach,Jeffrey N. Myers,Bonnie S. Glisson,Faye M. Johnson	66
3	The RAC1 P29S Hotspot Mutation in Melanoma Confers Resistance to Pharmacological Inhibition of RAF 2014 ·Cancer Research ·Ian R. Watson,Li Li,(unknown),(unknown),Tony Gutschner,Giannicola Genovese,Guocan Wang,Zhuangna Fang,James M. Tepper,Katherine Stemke‐Hale,Kenneth Y. Tsai,Michael A. Davies,Gordon B. Mills,Lynda Chin	116
4	Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population 2014 ·Tumor Biology ·Rachel Eyre,I. J. Harvey,Katherine Stemke‐Hale,Thomas W. J. Lennard,Alison Tyson-Capper,Annette Meeson	43
5	A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation 2014 ·BMC Cancer ·Kimberly C. Wiegand,Bryan T. Hennessy,Samuel Leung,Yemin Wang,Zhenlin Ju,(unknown),Steve E. Kalloger,Sarah Finlayson,Katherine Stemke‐Hale,Yiling Lu,Fan Zhang,Michael S. Anglesio,C. Blake Gilks,Gordon B. Mills,David G. Huntsman,Mark Carey	65
6	Gene Expression Profiling of Ampullary Carcinomas Classifies Ampullary Carcinomas into Biliary-Like and Intestinal-Like Subtypes That Are Prognostic of Outcome 2013 ·PLoS ONE ·Michael J. Overman,Jiexin Zhang,Scott Kopetz,Michael A. Davies,(unknown),Katherine Stemke‐Hale,Petra Rümmele,Christian Pilarsky,Robert Grützmann,(unknown),Rosa F. Hwang,James L. Abbruzzese,Gauri R. Varadhachary,Bradley M. Broom,Huamin Wang	42
7	Systematic analysis of genotype‐specific drug responses in cancer 2012 ·International Journal of Cancer ·Nayoung Kim,Ningning He,Chang Sik Kim,Fan Zhang,Yiling Lu,Qinghua Yu,Katherine Stemke‐Hale,Joel Greshock,Richard Wooster,Sukjoon Yoon,Gordon B. Mills	27
8	Detection algorithm for the validation of human cell lines 2012 ·International Journal of Cancer ·(unknown),(unknown),(unknown),(unknown),Gordon B. Mills,Katherine Stemke‐Hale	9
9	Genetic and molecular characterization of uveal melanoma cell lines 2012 ·Pigment Cell & Melanoma Research ·Klaus Griewank,Xiaoxing Yu,Jahan S. Khalili,Mert Sozen,Katherine Stemke‐Hale,Chantale Bernatchez,Seth Wardell,Boris C. Bastian,Scott E. Woodman	92
10	Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance 2012 ·Nature Medicine ·Justin M. Balko,Rebecca S. Cook,David Vaught,María G. Kuba,Todd W. Miller,Neil E. Bhola,Melinda E. Sanders,(unknown),J. Joshua Smith,Ingrid M. Meszoely,Janine Salter,Mitch Dowsett,Katherine Stemke‐Hale,Ana M. González-Angulo,Gordon B. Mills,Joseph A. Pinto,Henry Gómez,Carlos L. Arteaga	197
11	Breast cancer, side population cells and ABCG2 expression 2012 ·Cancer Letters ·(unknown),Rachel Eyre,I. J. Harvey,Katherine Stemke‐Hale,David Browell,Thomas W. J. Lennard,Annette Meeson	107
12	High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability 2011 ·Cancer Discovery ·Lydia W.T. Cheung,Bryan T. Hennessy,Jie Li,Shuangxing Yu,Andrea P. Myers,Bojana Djordjevic,Yiling Lu,Katherine Stemke‐Hale,Mary D. Dyer,Fan Zhang,Zhenlin Ju,Lewis C. Cantley,Steven E. Scherer,Han Liang,Karen H. Lu,Russell R. Broaddus,Gordon B. Mills	352
13	Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma 2011 ·Nature Genetics ·Todd D. Prickett,Xiaomu Wei,(unknown),Jamie K. Teer,Jimmy Lin,Vijay Walia,Jared J. Gartner,Jiji Jiang,Praveen F. Cherukuri,Alfredo A. Molinolo,Michael A. Davies,Jeffrey E. Gershenwald,Katherine Stemke‐Hale,Steven A. Rosenberg,Elliott H. Margulies,Yardena Samuels	115
14	Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer 2009 ·Clinical Cancer Research ·Roshan Agarwal,(unknown),Simen Myhre,Mark Carey,Ju‐Seog Lee,Jens Overgaard,Jan Alsner,Katherine Stemke‐Hale,Aňa Lluch,Richard M. Neve,Wen Lin Kuo,Thérese Sørlie,Ayşegül A. Şahin,Vicente Valero,Khandan Keyomarsi,Joe W. Gray,Anne‐Lise Børresen‐Dale,Gordon B. Mills,Bryan T. Hennessy	111
15	Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates 2009 ·Molecular Cancer Therapeutics ·Scott E. Woodman,Jonathan C. Trent,Katherine Stemke‐Hale,Alexander J. Lazar,Sabrina Pricl,Giovanni M. Pavan,Maurizio Fermeglia,Y.N. Vashisht Gopal,Dan Yang,Donald A. Podoloff,Doina Ivan,Kevin B. Kim,Nikolaos G. Papadopoulos,Patrick Hwu,Gordon B. Mills,Michael A. Davies	141
16	Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma 2009 ·Clinical Cancer Research ·Michael A. Davies,Katherine Stemke‐Hale,E. Lin,Carmen S. Tellez,Wanleng Deng,Y.N. Vashisht Gopal,Scott E. Woodman,Tiffany L. Calderone,Zhenlin Ju,Alexander J. Lazar,Víctor G. Prieto,Kenneth Aldape,Gordon B. Mills,Jeffrey E. Gershenwald	159
17	Molecular screening for breast cancer prevention, early detection, and treatment planning: Combining biomarkers from DNA, RNA, and protein 2006 ·Current Oncology Reports ·Katherine Stemke‐Hale,Bryan T. Hennessy,Gordon B. Mills,Rahul Mitra	7
18	Screening the whole genome of a pathogen in vivo for individual protective antigens 2005 ·Vaccine ·Katherine Stemke‐Hale,Bernhard Kaltenboeck,Fred J. DeGraves,Kathryn Sykes,Jin Huang,(unknown),Stephen Albert Johnston	23
19	A Library-Selected, Langerhans Cell-Targeting Peptide Enhances an Immune Response 2004 ·DNA and Cell Biology ·Michael J. McGuire,Kathryn Sykes,Kausar N. Samli,Laura Timares,Michael A. Barry,Katherine Stemke‐Hale,(unknown),Mark Logan,(unknown),Akira Takashima,Kathlynn C. Brown,Stephen Albert Johnston	23
20	Direct Association between the Yeast Rad51 and Rad54 Recombination Proteins 1996 ·Journal of Biological Chemistry ·Hua Jiang,Yueqing Xie,(unknown),Katherine Stemke‐Hale,Uffe Hasbro Mortensen,Rodney Rothstein,Thomas Kodadek	135

About Katherine Stemke‐Hale

Katherine Stemke‐Hale is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 54 papers that have together received 11.4k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (9 papers), Cancer Genomics and Diagnostics (8 papers) and Melanoma and MAPK Pathways (7 papers). The work is most often cited by research in Cancer Research (3.7k citations), Oncology (4.9k citations) and Pulmonary and Respiratory Medicine (4.3k citations). Katherine Stemke‐Hale has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Gordon B. Mills, Wandaliz Torres‐García, Emmanuel Martínez, Douglas A. Levine, Hui Shen, Roel G.W. Verhaak, Víctor Treviño, Kosuke Yoshihara, Maria Shahmoradgoli and Gad Getz. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact